NCT00185198 Efficacy and Safety of Testogel® in Men With Partial Androgen Deficiency of Aging Males (PADAM) Status COMPLETED Phase PHASE3
NCT00177970 IVIG Versus Placebo for the Treatment of Patients With Severe C-Diff Status TERMINATED Phase PHASE4
NCT00177138 Use of Campath for Induction and Maintenance Therapy in Pancreas After Kidney Transplantation Status TERMINATED Phase PHASE4
NCT00176280 Randomized Phase 2 Trial of Pre-chemotherapy Leukine vs. Leukine-Dexamethasone in Combination With Gemzar & 5-FU in Patients With Metastatic Renal Cell Carcinoma Status WITHDRAWN Phase PHASE2
NCT00171587 Study of the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Effects of Vatalanib in Combination With Capecitabine in Patients With Advanced Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00164463 TBTC Study 27/28 PK: Moxifloxacin Pharmacokinetics During TB Treatment Status COMPLETED Phase PHASE2
NCT00161590 Study of CHOP + Campath for T-Cell, Null Cell, or Natural Killer (NK)-Cell Lymphoma Status COMPLETED Phase PHASE1
NCT00160069 Safety and Efficacy Study of a New Chemotherapy Agent to Treat Non-small-cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00160043 Safety and Efficacy Study of a New Chemotherapy Agent to Treat Non Small Cell Lung Cancer. Status COMPLETED Phase PHASE2
NCT00157573 GM-CSF, Sargramostim in Women With Recurrent Ovarian Cancer Status COMPLETED Phase PHASE2
NCT00153062 PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes Status COMPLETED Phase PHASE4
NCT00144417 TBTC Study 28: Moxifloxacin Versus Isoniazid for TB Treatment Status COMPLETED Phase PHASE2
NCT00142272 Single Dose Ciprofloxacin in the Treatment of Childhood Cholera:Randomized Controlled Clinical Trial Status COMPLETED Phase PHASE3
NCT00142181 Phase II Study of Campath-1H Antibody to Treat Waldenstrom's Macroglobulinemia Status COMPLETED Phase PHASE2
NCT00139984 Ambulatory Blood Pressure Monitoring for Antihypertensive Treatment Guidance Status COMPLETED Phase PHASE4
NCT00137787 Comparing Ciprofloxacin (CPFX) With Cefepime (CFPM) in Febrile Neutropenic Patients With Hematologic Diseases Status COMPLETED Phase PHASE3
NCT00135226 ASCEND: A Study of Cardiovascular Events iN Diabetes Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT00119639 Study to Evaluate the Effect of Renal Function on the Single-Dose Pharmacokinetics of BAY 43-9006 Status COMPLETED Phase PHASE1
NCT00117637 BAY43-9006 (Sorafenib) Versus Interferon Alpha-2a in Patients With Unresectable and/or Metastatic Renal Cell Carcinoma Status COMPLETED Phase PHASE2